Vistin Pharma ASALTS:0RAM 77 Quick Ratio is 1.83 as of Mar. 2026, which is at its 10-year median of 1.83. GuruFocus rates LTS:0RAM with a GF Score™ of 77/100 and a GF Value™ of kr25.61 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 996 Drug Manufacturers companies, Vistin Pharma ASA ranks better than 60.94% on this metric.
Vistin Pharma ASA has a quick ratio of 1.83. It generally indicates good short-term financial strength.
The historical rank and industry rank for Vistin Pharma ASA's Quick Ratio or its related term are showing as below:
LTS:0RAM'
s Quick Ratio Range Over the Past 10 Years
Min: 0.59 Med: 1.83 Max: 7.82
Current: 1.83
During the past 13 years, Vistin Pharma ASA's highest Quick Ratio was 7.82. The lowest was 0.59. And the median was 1.83.
LTS:0RAM's Quick Ratio is ranked better than 60.94% of 996
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs LTS:0RAM: 1.83
Vistin Pharma ASA (LTS:0RAM) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Vistin Pharma ASA Quick Ratio Related Terms
Vistin Pharma ASA Quick Ratio Historical Data
* Premium members only.
The historical data trend for Vistin Pharma ASA's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0RAM vs ZTS, UTHR, VTRS: Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vistin Pharma ASA Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Vistin Pharma ASA's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Vistin Pharma ASA's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vistin Pharma ASA (LTS:0RAM) has a Quick Ratio of 1.83 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Vistin Pharma ASA and its competitors. This is near median its historical median of 1.83. Over the past decade, Vistin Pharma ASA's Quick Ratio has ranged from 0.59 to 7.82. According to the industry distribution chart, Vistin Pharma ASA ranks #389 out of 996 companies in the Drug Manufacturers industry, placing it in the top 39.1%.
Is Vistin Pharma ASA's Quick Ratio too high?
Vistin Pharma ASA's current Quick Ratio of 1.83 is near median its 10-year median of 1.83. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 7.82. The Drug Manufacturers industry median Quick Ratio is 1.45. Vistin Pharma ASA's value of 1.83 is 26.2% above this industry median. Based on the distribution chart, Vistin Pharma ASA ranks #389 out of 996 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Vistin Pharma ASA has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vistin Pharma ASA's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vistin Pharma ASA ranks #389 out of 996 companies for Quick Ratio. This puts Vistin Pharma ASA in the upper half of its industry. The industry median Quick Ratio is 1.45. Vistin Pharma ASA's value of 1.83 is 26.2% above this benchmark. Historically, Vistin Pharma ASA's own Quick Ratio has ranged from 0.59 to 7.82 over the past decade. While the company's 10-year median is 1.83 vs. the industry median of 1.45, Vistin Pharma ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vistin Pharma ASA's current Quick Ratio of 1.83 is 26.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Vistin Pharma ASA and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vistin Pharma ASA's current Quick Ratio is 1.83, which is near median its own 10-year median of 1.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vistin Pharma ASA stock overvalued right now?
Based on GuruFocus' analysis, Vistin Pharma ASA (LTS:0RAM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr25.61, compared to a current price of kr20.70 — trading 19.2% below its estimated fair value. The current Quick Ratio is 1.83, which is near median its 10-year median of 1.83 and 26.2% above the Drug Manufacturers industry median of 1.45. Vistin Pharma ASA's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Vistin Pharma ASA (LTS:0RAM), the current Quick Ratio is 1.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vistin Pharma ASA (LTS:0RAM) Overvalued in 2026?
Based on GuruFocus' analysis, Vistin Pharma ASA stock appears to be undervalued.
The current stock price of kr20.70 is trading 19.2% below its estimated GF Value™ of kr25.61.
GuruFocus considers Vistin Pharma ASA to be Modestly Undervalued.
Key valuation signals for LTS:0RAM:
Quick Ratio: 1.83 (near median its 10-year median of 1.83)
GF Value™: kr25.61 vs. price of kr20.70 (19.2% below fair value)
Industry Position: 26.2% above the Drug Manufacturers median (#389 of 996)
No single metric tells the full story. See the LTS:0RAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
77GF Score
Get the complete analysis for LTS:0RAM
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RAM has been successfully added to your 
